Deadline Nears for Investors in Securities Case Against Inspire Medical Over Inspire V Launch

Investors face a Jan. 5 deadline to seek lead-plaintiff status in the Minnesota case alleging misstatements about Inspire V’s launch.

Overview

The putative class action, City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, No. 0:25-cv-04247, is pending in the U.S. District Court for the District of Minnesota.
The case covers purchases of Inspire Medical stock from August 6, 2024 to August 4, 2025 and asserts claims under Sections 10(b) and 20(a) of the Exchange Act.
Plaintiffs allege the company overstated readiness and demand for Inspire V, citing incomplete training and onboarding at centers, delayed Medicare claims-processing updates effective July 1, 2025, and a surplus of older devices at customers.
On August 4, 2025, the company disclosed a longer rollout timeline and cut 2025 EPS guidance by more than 80%, followed by a $42.04, roughly 32%, share-price decline the next trading day.
Multiple investor firms, including Hagens Berman, Rosen Law, and Bleichmar Fonti & Auld, are soliciting potential lead plaintiffs, and no class has been certified.